# A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult Participants

> **NCT06418607** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 65 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Venglustat
- **DRUG:** Venglustat

## Key facts

- **NCT ID:** NCT06418607
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-23
- **Primary completion:** 2020-07-13
- **Final completion:** 2020-07-13
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2024-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06418607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06418607, "A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06418607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*